Hotchkis & Wiley Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
249,410
-232,110
-48% -$8.35M 0.03% 241
2026
Q1
$11.8M Buy
481,520
+64,590
+15% +$1.53M 0.04% 195
2025
Q4
$10.3M Sell
416,930
-4,780
-1% -$127K 0.03% 233
2025
Q3
$12M Buy
421,710
+129,270
+44% +$3.5M 0.04% 211
2025
Q2
$7.28M Buy
292,440
+113,020
+63% +$3.18M 0.02% 319
2025
Q1
$5.56M Buy
+179,420
New +$5.98M 0.02% 363

Other funds holding ASTH

Hotchkis & Wiley Capital Management's ASTH Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management reduced its Astrana Health (ASTH) stake by 48% in Q2 2026, selling an estimated $8.35M and leaving 249,410 shares worth $11.6M. The position accounts for 0.03% of the portfolio, ranked #241.

Hotchkis & Wiley Capital Management first reported a position in ASTH in Q1 2025 and has held it in 6 quarters since. The position peaked at $12M in Q3 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Hotchkis & Wiley Capital Management held 249,410 shares of Astrana Health worth $11.6M as of Q2 2026.
  • Hotchkis & Wiley Capital Management sold 232,110 Astrana Health shares in Q2 2026, an estimated $8.35M.
  • Astrana Health made up 0.03% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #241 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Astrana Health in Q1 2025 and has held it in 6 quarters since.
  • Hotchkis & Wiley Capital Management's Astrana Health position peaked at $12M in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.